Found 25 matching trials
Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2 PHASE1 This is a phase I study of second primary tumor prevention in early stage (...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR PHASE1 The safety, tolerability and recommended phase 2 dose (RP2D) of the combina...
Show More Location
National Cancer Centre Singapore
Learn More & Join Trial
Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma PHASE2 The purpose of this study is to test the safety and efficacy of the combina...
Show More Location
University of Colorado Hospital
Learn More & Join Trial
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor PHASE1 The goal of this clinical research study is to find the highest tolerable d...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Erlotinib and Temsirolimus for Solid Tumors PHASE1 Define the maximum tolerated dose and dose limiting side-effects of temsiro...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007) PHASE2 This is a Phase I/IIa study to evaluate safety and efficacy of dalotuzumab ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer PHASE2 Despite recent advances, most patients with advanced colorectal cancer cont...
Show More Location
Massachusett General Hospital
Learn More & Join Trial
Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy PHASE3 To determine if ZD6474 a new investigational drug, is effective in treating...
Show More Learn More & Join Trial
Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer PHASE2 The goal of this clinical research study is to learn about the safety and e...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash PHASE2 The purpose of this study is to evaluate the safety and preliminary efficac...
Show More Location
Northwestern University Robert H. Lurie Comprehensive Cancer Center
Learn More & Join Trial